News center

Sep 20, 2018

Philips showcases integrated solutions for cardiovascular care at TCT 2018


Innovations in image-guided therapy designed to enhance clinician confidence and improve patient care

Amsterdam, the Netherlands and San Diego, California – At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting (September 21 – 25, San Diego, California), Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, is showcasing its latest solutions in interventional cardiology. These solutions combine imaging systems, planning and navigation software, and specialized diagnostic and therapeutic devices, helping clinicians conduct procedures that are fast, efficient and personalized.
Philips will showcase its latest innovations in image-guided therapy, addressing key concerns of cardiologists such as complex percutaneous coronary interventions (complex PCI), which account for a significant proportion of PCI procedures that treat the narrowing of coronary arteries. Azurion, Philips’ next generation image-guided therapy platform, provides clinicians with the control needed to perform efficient procedures. CoreVision, which can be seamlessly combined with Azurion, is the only system that intelligently integrates X-ray angiography imaging, IVUS, and iFR in a single view for the high level of diagnostic precision needed for today’s increasingly complex procedures. Combining Philips’ imaging systems, planning and navigation, and smart devices, physicians can take advantage of an integrated solution that supports improved care for complex PCI patients.
Using our integrated high-precision solutions, comprising Azurion augmented with CoreVision and combined with our IVUS and iFR technologies, we’re able to provide clinicians with the right tools to make confident diagnosis and treatment decisions for each patient.

Christopher Barys

Business Leader Image Guided Therapy Devices, Philips

“Philips offers a unique portfolio of interventional cardiac technologies that cater to the complex needs of interventional cardiologists, enabling them to provide excellent treatment and care for their patients,” said Christopher Barys, Business Leader Image Guided Therapy Devices, Philips. “Using our integrated high-precision solutions, comprising Azurion augmented with CoreVision and combined with our IVUS and iFR technologies, we’re able to provide clinicians with the right tools to make confident diagnosis and treatment decisions for each patient.”

Latest advances in cardiac ultrasound for interventional procedures

This year at TCT, Philips will also showcase the recently-introduced EPIQ CVxi interventional cardiovascular ultrasound system. Specifically designed for use in the cath lab, the EPIQ CVxi with EchoNavigator streamlines communication between the interventional cardiologist and the echocardiographer during complex interventional exams, improving patient care and enhancing workflow. Combining live ultrasound and X-ray information into one intuitive view, EchoNavigator helps interventional cardiologists oversee procedures along with the location of key anatomical structures. In addition, MultiVue provides more flexibility when using 3D during diagnostic or interventional procedures as the clinician can see multiple views at once.

Also on show will be the compact and portable Philips CX50 ultrasound system, which has been upgraded with new software features and compatibility with additional transducers, including the latest X8-2t TEE transducer for transesophageal echocardiography. Philips has pioneered transesophageal echocardiography, which places the ultrasound transducer close to the heart to enable confident diagnosis and treatment of structural heart diseases. Now, customers will be able to use a wider range of transducers, including the X8-2t TEE, across both their mobile and cart-based ultrasound systems.

 

For the full calendar of events, as well as general information about Philips’ presence at the show, visit www.philips.com/tct. Visit Philips at booth #1728 to experience innovative cardiac solutions and follow the #TCT2018 conversation on @PhilipsLiveFrom throughout the event.

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 75,000 employees with sales and services in more than 100 countries. News about Philips can be found at http://www.philips.com/newscenter.

Read MoreRead Less

Topics

Contacts

Mark Groves

Mark Groves

Philips Group Press Office

Tel.: +31 631 639 916

Media assets

Philips CX50 ultrasound system, upgraded with new software features and compatibility
iFR is an innovative pressure-derived index unique to Philips.
Intravascular ultrasound (IVUS) is a catheter-based imaging technology that allows physicians to visualize blood vessels from the inside out
The Philips EPIQ CVxi with EchoNavigator streamlines communication between the interventional cardiologist and the echocardiographer

Press releases

Get our press releases by e-mail

Share on social media